TipRanks
Go Ultimate55% OFF

Inhibitor Therapeutics (INTI) Cash flow

Inhibitor Therapeutics Cash Flow

INTI's free cash flow for Q2 2026 was $-775.22K. For the 2026 fiscal year, INTI's free cash flow was increased by $0.00 and operating cash flow was $-775.22K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -3.23M$ -3.23M$ -2.70M$ 11.74M$ -220.43K
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ -411.00K$ 180.00K$ 176.00K
$ 2.38M$ 5.61M$ 8.84M$ 11.95M$ 30.63K
$ -3.23M$ -3.23M$ -2.70M$ 11.74M$ -220.43K

Currency in USD

Inhibitor Therapeutics Cash Flow

-5M05M10M15M201720182019202020212022202320242025OperatingInvestingFinancing